Previous 10 | Next 10 |
The Company will offer Ventis Pharma’s patented local anesthetic compound, Endura-Kit TM for post-operative surgical and chronic pain management InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a ...
After stumbling throughout much of 2021 and early 2022 to meet analyst expectations, INFU has righted the ship and looks to have a strong back half of 2022 in store. Investors seemed to have been spooked by a delay in finalizing a contract with GE Healthcare, but the now-revealed deta...
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard ...
InfuSystem press release (NYSE:INFU): Q1 GAAP EPS of -$0.02 beats by $0.01. Revenue of $26.8M (+9.4% Y/Y) beats by $0.87M. The company is providing annual guidance for FY2022 with net revenue growth estimated to be in the range of 15% to 20%, or approximately $118M to $123M in net revenues vs...
Signed 3-year Master Service Agreement with Leading Global Medical Technology and Diagnostic Company – Estimated Potential Annual Revenue of $10 Million to $12 Million Revenue Growth of 9% - Driven by 18% Growth in DME and 5% in ITS Strong Operating Ca...
InfuSystem (NYSE:INFU) said Thursday it entered into a three-year master service deal with a global healthcare technology and diagnostic firm, effective Apr. 25. INFU will provide its biomedical services to a majority of the fleet of infusion pumps at hospitals and other medical facilities un...
Preferred National Service Agreement to provide service and repair to fleet of more than 300,000 pumps in North America; Estimated $10-$12 million of annual revenue InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”...
Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment...
InfuSystem (NYSE:INFU) signed a national distribution agreement with Solo-Dex for its proprietary continuous nerve block catheters. The company said that with Solo-Dex catheter over the needle technology, all anesthesiologists can place facile continuous peripheral block catheter in two to th...
InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced a national distribut...
News, Short Squeeze, Breakout and More Instantly...
InfuSystems Holdings Inc. Company Name:
INFU Stock Symbol:
NYSE Market:
InfuSystems Holdings Inc. Website:
Investor Presentation to be held at 8:30 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufactu...
2024-05-21 23:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...